Boxed warning
Warnings For external use only
Warnings For external use only
Iluminage
POND'S INSTITUTE
YOUTH CELL
DAY CREAM
BROAD SPECTRUM
SPF 15 SUNSCREEN
50 ml e 1 .7 FL. OZ
GO UNDERCOVER IN BROAD DAYLIGHT
After 10 years of genomics research, the Pond’s
Institute scientists have decoded youth DNA
Pathways responsible for the self-renewing
Power of epidermal stem cells. This potent
24-hr hydrating cream contains patented
Survixyl ™ and CLA to help enhance skin’s
natural cell renewal and diminish the visible
signs of aging. Plus, this protective cream
formulated with board spectrum UVA/UVB
filters and vitamin E, helps shield skin from
environmental aggressors such as the sun
and free radicals, What do you see? A visible
reduction in the appearance of fine lines and
wrinkles, a smoother texture and a more
even, radiant skin tone. Apply after using the
SKIN SMOOTHING LASER™ to give skin added
protection.
DERMATOLOGIST TESTED
ADVANCE TECHNOLOGIES
-SURVIXYL™, “The youth cell bodyguard:
Helps support skin’s natural ability to defend
itself against stress and visible signs of aging.
-CLA, “The anti-aging power house”: works
within deepest surface layers to boost skin’s
natural cell renewal.
PROVEN TO CHANGE THE WAY
YOU SEE YOUR SKIN*
-90% of women noticed a smoother skin
Texture.
-73% of women saw a reduction in the
appearance of fine lines and wrinkles
-85% of women saw an enhancement in
skin’s natural radiance
*Consumer in-use test on 119 volunteers (results after 4 weeks).
Made in USA
Distributed by Iluminage™, inc.
243 5th Avenue, Suite #110
New York, NY 10016
Iluminagebeauty.com
I103100 1-855-myiluminage (694-5864)
Drug Facts
Active ingredients
Avobenzone 3%
Octinoxate 6%
Octisalate 3%
Octocrylene 2.4%
Purpose
Sunscreen
Uses
-helps prevent sunburn
If used as directed with other sun
protection measures (See Directions),
decreases the risk of skin cancer and
early skin aging cause by the sun.
Warnings
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes.
Rinse with water to remove.
Stop use and ask a doctor if rash occurs
Keep out of reach of children. If swallowed,
get medical help or contact a Poison
Control Center right away.
Directions
-apply generously and evenly to face
and neck 15 minutes before sun
exposure.
-reapply at least every 2 hours
-use a water resistant sunscreen if
swimming or sweating.
-children under 6 months of age. Ask a
doctor
-Sun Protection Measures, Spending time
in the sun increases your risk of skin cancer
and early skin aging. To decrease this risk,
regularly use a sunscreen with a Board
Spectrum SPF value of 15 or higher and
other sun protection measures including:
-limit time in the sun, especially from
10 a.m. – 2 p.m.
-wear long-sleeved shirts, pants, hats,
and sunglasses.
Other information
-protect the product in this container
from excessive heat and direct sun
Drug Facts (continued)
Inactive ingredients
Water/Aqua, Cyclopentasiloxane, Nia-
cinamide, Glycerin, Cetearyl Alcohol,
Dimethicone, PEG-100 Stearate, Poly-
Methylsilsesquixane, Isomerized Linoleic
Acid, Tocopheryl Acetate, Cholesterol,
Stearic Acid, Caprylic/Capric Triglyceride,
Pentapeptide-31, Ammonium
Acryloydimethyltaurate/Beheneth-25
Methylacrylate Crosspolymer, Tocopherol,
Behenyl Alcoho, Palmitic Acid, Linoleic
Acid, Oleic Acid, Ceteareth-20, Butylene
Glycol, Cetyl Alcohol, Stearyl Alcohol,
Arachidyl Alcohol, Ammonium Lactate,
Pentaerythiryl Tetra-di-t-butyl Hydro-
Xyhydrocinnamate, Isohexadecane, Poly-
Methyl Methacrylate, Sodium Polyacry-
Loyldimethyl Taurate, Ethylene/Arcylic
Acid Copolymer, Poloxamer 338, Silica,
Hydrogenated Polydecene, Trideceth-10,
Dimethiconol, Calcium Aluminum
Borosilicate, Methylisothiszolinone, Cap-
prylyl Glycol, Fragrance, Acetamide MEA,
Polyglycerin-3, BHT, Phenoxyethanol,
Propylene Glycol, Sodium Benzoate,
Citric Acid, Disodium EDTA, Limonene,
Linalool, tin Oxide. Titanium Dioxide
(CI 77891).
THE BEAUTY OF SMART™
Award-winning scientists at the Pond’s Institute
have collaborated with a team of luminaries in
the field of dermatology to break the boundaries
of skincare. For the first time, science, technology
and complete interactivity join forces to create
a skincare system so effective it’s the last one
you’ll ever need.
THE ILUMINAGE ™ SKIN CLINIC
Get smart. Visit the Iluminage ™ Skin Clinic for
A complete interactive experience. Access
Iluminage ™ Skin Specialists in person, online,
Or by phone. Plus, maintain your own personal
Progress page online and on-the-go. Join
Our skincare community, participate in
the conversation and see the light at
iluminagebeauty.com
Avobenzone 3%
Octinoxate 6%
Octisalate 3%
Octocrylene 2.4%
Sunscreen
Warnings
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes.
Rinse with water to remove.
Stop use and ask a doctor if rash occurs
Keep out of reach of children. If swallowed,
get medical help or contact a Poison
Control Center right away.
Directions
-apply generously and evenly to face
and neck 15 minutes before sun
exposure.
-reapply at least every 2 hours
-use a water resistant sunscreen if
swimming or sweating.
-children under 6 months of age. Ask a
doctor
-Sun Protection Measures, Spending time
in the sun increases your risk of skin cancer
and early skin aging. To decrease this risk,
regularly use a sunscreen with a Board
Spectrum SPF value of 15 or higher and
other sun protection measures including:
-limit time in the sun, especially from
10 a.m. – 2 p.m.
-wear long-sleeved shirts, pants, hats,
and sunglasses.
Inactive ingredients
Water/Aqua, Cyclopentasiloxane, Nia-
cinamide, Glycerin, Cetearyl Alcohol,
Dimethicone, PEG-100 Stearate, Poly-
Methylsilsesquixane, Isomerized Linoleic
Acid, Tocopheryl Acetate, Cholesterol,
Stearic Acid, Caprylic/Capric Triglyceride,
Pentapeptide-31, Ammonium
Acryloydimethyltaurate/Beheneth-25
Methylacrylate Crosspolymer, Tocopherol,
Behenyl Alcoho, Palmitic Acid, Linoleic
Acid, Oleic Acid, Ceteareth-20, Butylene
Glycol, Cetyl Alcohol, Stearyl Alcohol,
Arachidyl Alcohol, Ammonium Lactate,
Pentaerythiryl Tetra-di-t-butyl Hydro-
Xyhydrocinnamate, Isohexadecane, Poly-
Methyl Methacrylate, Sodium Polyacry-
Loyldimethyl Taurate, Ethylene/Arcylic
Acid Copolymer, Poloxamer 338, Silica,
Hydrogenated Polydecene, Trideceth-10,
Dimethiconol, Calcium Aluminum
Borosilicate, Methylisothiszolinone, Cap-
prylyl Glycol, Fragrance, Acetamide MEA,
Polyglycerin-3, BHT, Phenoxyethanol,
Propylene Glycol, Sodium Benzoate,
Citric Acid, Disodium EDTA, Limonene,
Linalool, tin Oxide. Titanium Dioxide
(CI 77891).
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69047-001-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-469f-f424-e053-dadaa90a57ce | 1bf755b3-dc48-4ad0-9b26-33ff0723015c |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69047-001-01 | Youth Cell Day Cream Broad Spectrum SPF-15 Sunscreen (50 ml) | 50 mL in 1 BOTTLE, PUMP | CREAM | 50 | 1 | |
| 69047-001-02 | Youth Cell Day Cream Broad Spectrum SPF-15 Sunscreen (50 ml) | 1 in 1 BOX | CREAM | 1 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| ACETAMIDE | INACTIVE INGREDIENT | 8XOE1JSO29 | 1 | |
| AMMONIUM ACRYLOYLDIMETHYLTAURATE/BEHENETH-25 METHACRYLATE CROSSPOLYMER (52000 MPA.S) | INACTIVE INGREDIENT | LZ291VH90H | 1 | |
| AMMONIUM LACTATE | INACTIVE INGREDIENT | 67M901L9NQ | 1 | |
| ARACHIDYL ALCOHOL | INACTIVE INGREDIENT | 1QR1QRA9BU | 1 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CALCIUM ALUMINUM BOROSILICATE | INACTIVE INGREDIENT | 3JRB8A35M0 | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| CHLORPHENESIN | INACTIVE INGREDIENT | I670DAL4SZ | 1 | |
| CHOLESTEROL | INACTIVE INGREDIENT | 97C5T2UQ7J | 1 | |
| CHONDRUS CRISPUS | INACTIVE INGREDIENT | OQS23HUA1X | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| CYCLOMETHICONE 4 | INACTIVE INGREDIENT | CZ227117JE | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| DIMETHICONOL (2000 CST) | INACTIVE INGREDIENT | T74O12AN6Y | 1 | |
| DOCOSANOL | INACTIVE INGREDIENT | 9G1OE216XY | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| HYDROGENATED POLYDECENE (550 MW) | INACTIVE INGREDIENT | U333RI6EB7 | 1 | |
| ISOHEXADECANE | INACTIVE INGREDIENT | 918X1OUF1E | 1 | |
| LINOLEIC ACID | INACTIVE INGREDIENT | 9KJL21T0QJ | 1 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| METHYLISOTHIAZOLINONE | INACTIVE INGREDIENT | 229D0E1QFA | 1 | |
| MICA | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| NIACINAMIDE | INACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| OLEIC ACID | INACTIVE INGREDIENT | 2UMI9U37CP | 1 | |
| PALMITIC ACID | INACTIVE INGREDIENT | 2V16EO95H1 | 1 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) | INACTIVE INGREDIENT | 255PIF62MS | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLOXAMER 338 | INACTIVE INGREDIENT | F75JV2T505 | 1 | |
| POLY(METHYL METHACRYLATE; 450000 MW) | INACTIVE INGREDIENT | Z47NNT4J11 | 1 | |
| POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) | INACTIVE INGREDIENT | 59Z907ZB69 | 1 | |
| POLYOXYL 20 CETOSTEARYL ETHER | INACTIVE INGREDIENT | YRC528SWUY | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | 1 | |
| SODIUM DEHYDROACETATE | INACTIVE INGREDIENT | 8W46YN971G | 1 | |
| STANNIC OXIDE | INACTIVE INGREDIENT | KM7N50LOS6 | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| STEARYL ALCOHOL | INACTIVE INGREDIENT | 2KR89I4H1Y | 1 | |
| TERT-BUTYL ALCOHOL | INACTIVE INGREDIENT | MD83SFE959 | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| TRIDECETH-10 | INACTIVE INGREDIENT | G624N6MSBA | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69047-001 | 69047-001-01, 69047-001-02 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | DROPS / ORAL | NA | ||
| CHOLESTEROL | CHOLESTEROL | 97C5T2UQ7J | LOTION / TOPICAL | 20 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | CREAM / TOPICAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / DENTAL | 0.08 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / ORAL | 269 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / AURICULAR (OTIC) | 0.05 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAVENOUS | 864 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | CAPSULE, EXTENDED RELEASE / ORAL | 9.43 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / NASAL | 0.1 mg/1ml | ||
| STEARYL ALCOHOL | STEARYL ALCOHOL | 2KR89I4H1Y | POWDER / ORAL | 0.11 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / TOPICAL | 0.1 %w/v | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAMUSCULAR | 2.5 %w/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | PASTE / DENTAL | 34 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SPRAY, METERED / SUBLINGUAL | 110 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | GEL / TOPICAL | 0.06 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER, FOR SUSPENSION / ORAL | 3390 mg/5ml | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INFILTRATION | 6 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | LOTION / TOPICAL | 7 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | LOTION / TOPICAL | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / TOPICAL | 126 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, FOR SUSPENSION / ORAL | 0.1 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION, CONCENTRATE / ORAL | 0.1 mg/1ml | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUSPENSION / ORAL | 113 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / VAGINAL | 6.4 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CAPSULE / ORAL | 5 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, EXTENDED RELEASE / ORAL | 450 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SYSTEM / TOPICAL | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| PALMITIC ACID | PALMITIC ACID | 2V16EO95H1 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | ELIXIR / ORAL | 9306 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 11f4dd9c-4dc1-41b9-be80-220568b72e45 | 1bf755b3-dc48-4ad0-9b26-33ff0723015c | 2014-06-20 | Boxed warning | 11f4dd9c-4dc1-41b9-be80-220568b72e45 1bf755b3-dc48-4ad0-9b26-33ff0723015c |
Adverse event summaries are temporarily unavailable. Other product information remains available.